The interplay of plant polysaccharide structure, gut microbiota metabolism, and host health: Mechanisms and perspectives
Clinical Snapshot
PICO Framework
| P — Population | Human and animal subjects with gut microbiota |
| I — Intervention | Plant polysaccharides with varying chemical structures |
| C — Comparator | Different polysaccharide structures or control conditions |
| O — Outcomes | Gut microbiota composition, metabolite production (SCFAs), and health outcomes (obesity, diabetes, IBD, NAFLD) |
Bottom Line
This systematic review examines how plant polysaccharide chemical structures influence gut microbiota metabolism and subsequent health outcomes. While the topic is clinically relevant, particularly for metabolic and inflammatory conditions, the review's methodological rigor cannot be adequately assessed from available information. The authors identify key mechanisms involving glycoside hydrolases and short-chain fatty acid production, with implications for obesity, diabetes, IBD, and NAFLD. However, without clear methodology, quality assessment, or quantitative synthesis, the evidence strength remains uncertain. Clinicians should await more rigorous systematic reviews or well-designed clinical trials before making specific therapeutic recommendations regarding plant polysaccharides for gut health modulation.
Key Findings
P Value: Not applicable for narrative review
Effect Size: Not specified in available information
Primary Outcome: Plant polysaccharide structure influences gut microbiota composition and metabolic function
Nnt Or Sensitivity: Not applicable - mechanistic review without therapeutic intervention data
Confidence Interval: Not reported
Clinical Application
Limited by lack of specific dosing recommendations and standardized polysaccharide preparations Relevant to Australian dietary guidelines and complementary medicine regulations under TGA; potential applications in functional foods and nutraceuticals Patients with metabolic disorders, IBD, and NAFLD; general population interested in gut health
Abstract
Plant polysaccharides, as natural biomolecules, possess the capability to modulate the structure and function of gut microbiota, subsequently influencing host health. Nevertheless, the molecular mechanisms underlying their interactions remain insufficiently understood. This article presents a systematic review of the impact of the chemical structure of plant polysaccharides, including monosaccharide composition and types of glycosidic bonds, on the metabolic preferences of gut microbiota. It emphasizes how structural variations in polysaccharides can promote the proliferation of specific gut microbiota, such as Bacteroidetes and Firmicutes. Additionally, the study analyzes critical enzymatic systems, including glycoside hydrolases (GHs) and polysaccharide lyases (PLs), alongside metabolic pathways associated with the production of short-chain fatty acids (SCFAs) that facilitate the degradation of plant polysaccharides by gut microbiota. Furthermore, it explores the influence of these metabolites on conditions such as obesity, diabetes, inflammatory bowel disease (IBD), and non-alcoholic fatty liver disease. The findings provide a robust theoretical framework for enhancing the utilization efficiency of bioactive polysaccharide components through targeted extraction and characterization techniques, thereby fostering potential advancements in innovative nutritional formulations and pharmacological applications.
References
- 1.Zhang, J., Ma, Y., Chang, R., Wang, R., & Zhang, J. (2026). The interplay of plant polysaccharide structure, gut microbiota metabolism, and host health: Mechanisms and perspectives. Life Sciences, 124383. https://doi.org/10.1016/j.lfs.2026.124383
Related Research
The American journal of pathology
An Integrated Machine Learning and Genomic Framework for Precise Detection of Gastric Cancer
3 Aug 2026
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Artificial Intelligence Tools for Gastrointestinal Research: A Practical Guide
2 Aug 2026
Current opinion in critical care
Smart feeding: the role of artificial intelligence and integrated nutrition platforms in the ICU
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service